Analyst Mani Foroohar works at LEERINK and is focused on the Healthcare sector with 405 price targets and ratings documented since 2018 spanning on 25 stocks. Analyst's average stock valuation to be materialised ratio is 34.12% with an average time for price targets to be met of 116.8 days.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals, Inc at 23-Jan-2023.
Mani Foroohar best performing recommendations are on FDMT.
The best stock recommendation documented was for FDMT at 11/14/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.51 (11.19%) receiving and performance score of 111.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
2
$1.3 (185.71%)
2.5
2 months 26 days ago
0/2 (0%)
$1.13 (114.91%)
Hold
2
$1.3 (185.71%)
5
1 years 6 months 14 days ago
3/5 (60%)
$3.07 (29.73%)
47
Hold
3
$2.3 (328.57%)
21
1 years 6 months 14 days ago
4/5 (80%)
$3.63 (50.89%)
139
Hold
21
1 years 6 months 14 days ago
2/2 (100%)
$7.53 (88.83%)
197
Buy
6
$5.3 (757.14%)
30
1 years 9 months 8 days ago
1/3 (33.33%)
$4.81 (39.30%)
34
